Tilray Brands, Inc.

TLRY.TO · Toronto Stock Exchange · CAD

4,05CAD

−0,07 (−1,70 %)Stand 9. Nov., 21:00

Vortag 4,12

Kennzahlen

Eröffnung
4,15
Vortag
4,12
Tagesspanne
3,97 – 4,15
52 Wochen
1,08 – 21,57
Volumen
604.888
Ø Volumen
596.275
Börsenwert
598,54 Mio. CAD
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
1,9
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Tilray Brands, Inc. operates as a global enterprise deeply involved in the entire lifecycle of cannabis products, from initial research and cultivation to manufacturing, marketing, and distribution. Its reach extends across a multitude of international markets, including Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company's diverse operations are segmented into four key areas: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. Within its portfolio, Tilray provides a broad spectrum of medical and adult-use cannabis offerings, such as GMP-certified flowers, oils, vapes, edibles, and topicals. Beyond cannabis, the company also procures and resells various pharmaceutical and wellness products. Furthermore, Tilray is active in the production, promotion, and distribution of alcoholic beverages, alongside hemp-based food items and other wellness-focused goods. These numerous products are marketed under a wide array of brands, including Tilray, Aphria, Broken Coast, SweetWater, Breckenridge Distillery, and others. The company’s sales channels are extensive, serving retailers, wholesalers, individual patients, physicians, hospitals, pharmacies, researchers, government entities, and direct-to-consumer markets. Previously named Tilray, Inc., the corporation's main headquarters are situated in Leamington, Canada.

CEO
Irwin David Simon
Mitarbeitende
3.595
Hauptsitz
Leamington, ON, CA
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
5. Mai 2021
Website
tilray.com

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.